S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

$28.88
+1.51 (+5.52%)
(As of 03/27/2024 ET)
Today's Range
$27.36
$28.90
50-Day Range
$19.70
$32.15
52-Week Range
$15.10
$39.05
Volume
1.64 million shs
Average Volume
1.95 million shs
Market Capitalization
$4.29 billion
P/E Ratio
N/A
Dividend Yield
3.46%
Price Target
$28.22

Chemours MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
2.3% Downside
$28.22 Price Target
Short Interest
Healthy
3.33% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.15mentions of Chemours in the last 14 days
Based on 37 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
17.85%
From $2.97 to $3.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.60 out of 5 stars

Basic Materials Sector

133rd out of 172 stocks

Chemicals & Allied Products Industry

10th out of 13 stocks

CC stock logo

About Chemours Stock (NYSE:CC)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CC Stock Price History

CC Stock News Headlines

The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
Chemours fourth-quarter loss narrows
Your $200 account credit is about to expire
Update to MarketBeat All Access and Save $300 on Your Annual Subscription
Chemours (CC) Scheduled to Post Quarterly Earnings on Thursday
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/28/2023
Ex-Dividend for 3/15 Dividend
2/23/2024
Dividend Payable
3/15/2024
Today
3/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$28.22
High Stock Price Target
$40.00
Low Stock Price Target
$19.00
Potential Upside/Downside
-2.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
8 Analysts

Profitability

Net Income
$578 million
Pretax Margin
-5.10%

Debt

Sales & Book Value

Annual Sales
$6.79 billion
Cash Flow
$7.01 per share
Book Value
$7.34 per share

Miscellaneous

Free Float
146,018,000
Market Cap
$4.29 billion
Optionable
Optionable
Beta
1.97
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

CC Stock Analysis - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price target for 2024?

8 analysts have issued 1 year target prices for Chemours' stock. Their CC share price targets range from $19.00 to $40.00. On average, they anticipate the company's stock price to reach $28.22 in the next twelve months. This suggests that the stock has a possible downside of 2.3%.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2024?

Chemours' stock was trading at $31.54 at the start of the year. Since then, CC shares have decreased by 8.4% and is now trading at $28.88.
View the best growth stocks for 2024 here
.

Are investors shorting Chemours?

Chemours saw a decline in short interest in the month of February. As of February 15th, there was short interest totaling 4,640,000 shares, a decline of 5.9% from the January 31st total of 4,930,000 shares. Based on an average trading volume of 1,170,000 shares, the short-interest ratio is presently 4.0 days. Approximately 3.2% of the shares of the company are sold short.
View Chemours' Short Interest
.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024.
View our CC earnings forecast
.

How can I listen to Chemours' earnings call?

Chemours will be holding an earnings conference call on Thursday, March 28th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) posted its earnings results on Friday, July, 28th. The specialty chemicals company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.09 by $0.01. The specialty chemicals company earned $1.64 billion during the quarter, compared to analysts' expectations of $1.75 billion. Chemours had a negative net margin of 5.13% and a positive trailing twelve-month return on equity of 42.13%. During the same period in the previous year, the firm posted $1.89 earnings per share.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours announced a quarterly dividend on Monday, February 12th. Shareholders of record on Monday, February 26th will be paid a dividend of $0.25 per share on Friday, March 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.46%. The ex-dividend date is Friday, February 23rd.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.52%.
Read our dividend analysis for CC.

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY 2023 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.0 billion-$6.0 billion, compared to the consensus revenue estimate of $6.0 billion.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.80%), Vanguard Group Inc. (10.80%), Massachusetts Financial Services Co. MA (3.21%), Dimensional Fund Advisors LP (1.72%), LSV Asset Management (1.59%) and Vaughan Nelson Investment Management L.P. (0.93%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners